ScholarWorks@Hanyang University: Choi, Dongho

Detailed Information

Choi, Dongho (최동호)

서울 의과대학 (DEPARTMENT OF SURGERY)

Research Area: 외과학(간담췌)

Tel 02-2290-8449
Homepage

ResearcherID ORCiD Scopus Google Scholar ID ResearchGate

Keyword

Bile juice:5||Hepatocellular carcinoma:4||Human chemically derived hepatic progenitors:4||Gallbladder cancer:3||prognosis:3||Prognosis:3||Reprogramming:3||Hepatocytes:3||hepatocellular carcinoma:3||Bioprinting:3||Cholecystectomy:2||Liver:2||Human hepatocytes:2||Diet:2||Au nanodendrite:2||Gall bladder disease:2||Liver regeneration:2||standardised incidence ratio:2||Immunohistochemistry:2||Liver transplantation:2||Small molecules:2||Hepatocyte:2||Induced pluripotent stem cells:2||immunohistochemistry:2||Surface enhanced Raman scattering:2||Stem cells:2||cancer incidence:2||Pancreatectomy:2||Infrared spectroscopy:2||Culture:2||3D printing:2||Jehovah&apos:2||cholecystectomy:2||Cell Differentiation:2||Hepatectomy:2||Critical view of safety:1||Cryopreservation:1||DNA methylation:1||DUSP1:1||DUSP4:1||Deuterated chloroform:1||Diabetes:1||Dietary pattern:1||Dimethyl sulfoxide:1||Direct conversion:1||Discriminant analysis:1||Discrimination:1||Disease discrimination:1||Disease modeling:1||Disease screening:1||Donor memory:1||Drug screening:1||Dualspecificity phosphatase 4:1||EGFR:1||Electrospun fiber scaffold:1||Entecavir:1||EpCAM:1||Epigenomics:1||Erectile dysfunction:1||Erythropoietin:1||Ex vivo gene editing:1||Exosome:1||Exosomes:1||Experimental animal model:1||Fibrosis:1||Followup studies:1||Gall bladder cancer:1||Gallbladder polyp:1||Gallbladder stone:1||Gallstone:1||Gastric cancer:1||Gene editing:1||Genomics:1||Glissonian approach:1||Graft Rejection:1||Graft rejection:1||HCC xenograft mouse model:1||HCV Core:1||HER2:1||Hemodialysis:1||Hemodilution:1||Hep G2 cell:1||Hepatic cell sheet and hepatic patch:1||Hepatic differentiation:1||Hepatic function:1||Hepatic progenitors:1||Hepatitis B virus:1||Hepatocyte lineage cells:1||Hepatopancreaticobiliary (HPB) diseases:1||Hepatotoxicity:1||HighThoughput Nucleotide Sequencing:1||Human chemically derived hepatic progenitors (hCdHs):1||Human chemicallyderived hepatic progenitors:1||Human derived pluripotent stem cells:1||Human primary hepatocytes (hPHs):1||Imaging:1||Immune tolerance:1||Immunosuppression therapy:1||In vitro testing:1||Incidence:1||Interlukin6:1||Invasion and migration:1||Iron isomaltoside:1||Jugular vein:1||Kidney transplantation:1||Korean:1||Laparoscopic cholecystectomy:1||Learning curve:1||Lipid extraction:1||Liver Organoid:1||Liver disease:1||Liver neoplasms:1||Liver organoids:1||Liver tissue engineering:1||MET:1||Machine perfusion:1||Magnetic resonance imaging:1||Magnetofection:1||Maintenance:1||Malignancy:1||Maturation:1||Mesenchymal stem cell transplantation:1||Mesenchymal stem cells:1||Microarray analysis:1||Molecular fingerprinting:1||Monoclonal antibody NPB15:1||Morbid obesity:1||Mouse induced hepatocytes:1||Multiple primary cancer:1||Mycoplasmal p37 protein:1||Nanobiotechnology:1||Nanoparticles:1||Nearinfrared spectroscopy:1||Neuroendocrine tumors:1||Nickel foam:1||Nonalcoholic fatty liver disease:1||Oncolytic adenovirus:1||Organ Transplantation:1||Organ transplantation:1||PEGylated and crosslinked iron oxide nanoparticles (PCION):1||PI3K/AKT pathway:1||Pancreatic neoplasms:1||Pancreaticoduodenectomy:1||Pancreaticojejunostomy:1||Patient blood management:1||Patient with cholecystectomy:1||Phospholipid:1||Pigment gallstone:1||Postcholecystectomy syndrome:1||Postoperative pancreatic fistula:1||Primate:1||Prime editor:1||Printing:1||Quality standards:1||Regenerative Medicine:1||Regenerative medicine:1||Renal dysfunction:1||Renewable energy:1||Retinoic acid receptorbeta(2):1||SALL4 protein:1||SSBP2:1||Singlestranded DNA binding protein 2:1||Stem Cells:1||Stem cell therapy:1||Surgical resident:1||Surgical training:1||Tenofovir:1||ThreeDimensional:1||Threedimensional printing:1||Tissue array analysis:1||Tissue engineering:1||Transcription Factors:1||Transduodenal ampullectomy:1||Transfusion free:1||Transfusionfree surgery:1||Triplenegative breast cancer:1||Tumor microenvironment:1||Twotrace twodimensional correlation analysis:1||UPF1:1||Vascular access:1||Waste valorization:1||Xenotransplantation:1||adenine base editor:1||adjuvant chemotherapy:1||adjuvant radiotherapy:1||adjuvant treatment:1||ampulla of Vater:1||apoptosis:1||apoptotic protease activating factor 1:1||artificial liver:1||bile duct reconstruction:1||biliary:1||biliary tract cancer:1||cell proliferation:1||cell transplantation:1||chemically derived hepatic progenitor:1||chemically derived hepatic progenitors:1||cholangiocarcinoma:1||cholangiocytes:1||colorectal cancer:1||complication:1||customized scaffold:1||dip coating:1||direct conversion:1||dualspecificity protein phosphatase 4:1||electrospun fibers:1||ex vivo gene editing therapy:1||exosome:1||gallbladder adenocarcinoma:1||gallbladder cancer:1||gene amplification:1||gene expression:1||genetic disorder:1||hepatic organoids:1||hepatocyte differentiation:1||hepatocyte maturation:1||hiPSCs:1||histology directed MALDI:1||human adipose stem cell:1||hypoxiainducible factor 1 alpha:1||immunosuppression:1||induced hepatocyte:1||kidney:1||laparoscopic cholecystectomy:1||liver:1||living donors:1||medical imaging:1||mesenchymal stem cells:1||miHep cells:1||mortality:1||multicellular hepatic microtissue:1||myelin expression factor 2:1||n3 polyunsaturated fatty acid:1||p16:1||pancreatic cancer:1||patientspecific bile duct:1||posttranscriptional regulation:1||primary hepatocytes:1||prime editing:1||prognostic factor:1||regenerative medicine:1||reprogramming:1||s Witness:1||s witnesses:1||stem cells:1||suppression:1||surgical resident:1||threedimensional:1||training:1||transfusion:1||transgenefree:1||transplantation:1||tumor progression:1||3D bioprinting:1||tyrosinemia type 1:1||3D bioprinting:1||3D culture:1||Alltrans retinoic acid:1||Ampullary tumor:1||Ampullectomy:1||Anastomotic leak:1||Animal models:1||Antitumor activity:1||Asia:1||Bile acid:1||Biliary IPMN:1||Biliary regeneration:1||Bioartificial liver:1||Biodiesel:1||Biofuel:1||Blood transfusion:1||Bloodless medical and surgical procedures:1||CD47 antigen:1||CD98:1||CRISPR:1||Cancer gene therapy:1||Carbon neutrality:1||Cell Biology:1||Cell culture:1||Cell isolation:1||Cellular Reprogramming:1||Chemically derived hepatic progenitors:1||Cholangiocytes:1||Cholangiopathies:1||Cholesterol gallstone:1||Circulating tumor cell:1||Collagen:1||Collagen organoid:1||CreloxP system:1||

RSS_1.0 RSS_2.0 ATOM_1.0

222, Wangsimni-ro, Seongdong-gu, Seoul, 04763, Korea+82-2-2220-1366

Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.

Detailed Information

Keyword

BROWSE